APO RESEARCH · REPORT
Self Injection Device
The injectors were initially designed to overcome the hesitation associated with self-administration of the needle-based drug delivery device.
Product & engineering
Understand the product.
The injectors were initially designed to overcome the hesitation associated with self-administration of the needle-based drug delivery device.
An auto-injector is a medical device designed to deliver a dose of a particular drug.
Selected research
Market Structure
Global Self Injection Device Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The injectors were initially designed to overcome the hesitation associated with self-administration of the needle-based drug delivery device.
An auto-injector is a medical device designed to deliver a dose of a particular drug.
Market competition is not intense. Novo Nordisk, Mylan, Pfizer, Sanofi, BD, Eli Lilly and Gerresheimer, etc. are the leaders of the industry, with about 60% market shares.
Read the full market overview
Europe is the largest consumption place, with a consumption market share nearly 42%. Following Europe, North America is the second largest consumption place with the consumption market share of 31%.
This report provides an overview of the global Self Injection Device market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Self Injection Device and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Self Injection Device sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Self Injection Device market size, projected growth trends, production technologies, key applications, and end-use industries.
Self Injection Device Segment by Company
Novo Nordisk
Mylan
Pfizer
Sanofi
BD
Eli Lilly
Gerresheimer
Dongbao
Ypsomed
Owen Mumford
Antares Pharma
Haselmeier
Self Injection Device Segment by Type
Reusable Self Injection Device
Disposable Self Injection Device
Self Injection Device Segment by Application
Insulin Injection
Epinephrine Injection
Others
Self Injection Device Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Self Injection Device market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Self Injection Device and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Self Injection Device.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Self Injection Device market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Self Injection Device manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Self Injection Device in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Self Injection Device in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Reusable Self Injection Device
- Disposable Self Injection Device
Applications
- Insulin Injection
- Epinephrine Injection
- Others
Companies covered
- Novo Nordisk
- Mylan
- Pfizer
- Sanofi
- BD
- Eli Lilly
- Gerresheimer
- Dongbao
- Ypsomed
- Owen Mumford
- Antares Pharma
- Haselmeier
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Self Injection Device Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Self Injection Device Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Self Injection Device Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Self Injection Device Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Self Injection Device Market Dynamics
- 2.1 Self Injection Device Industry Trends
- 2.2 Self Injection Device Industry Drivers
- 2.3 Self Injection Device Industry Opportunities and Challenges
- 2.4 Self Injection Device Industry Restraints
3 Self Injection Device Market by Manufacturers
- 3.1 Global Self Injection Device Revenue by Manufacturers (2021-2026)
- 3.2 Global Self Injection Device Sales by Manufacturers (2021-2026)
- 3.3 Global Self Injection Device Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Self Injection Device Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Self Injection Device Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Self Injection Device Manufacturers, Product Type & Application
- 3.7 Global Self Injection Device Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Self Injection Device Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Self Injection Device Players Market Share by Revenue in 2025
- 3.8.3 2025 Self Injection Device Tier 1, Tier 2, and Tier 3
4 Self Injection Device Market by Type
- 4.1 Self Injection Device Type Introduction
- 4.1.1 Reusable Self Injection Device
- 4.1.2 Disposable Self Injection Device
- 4.2 Global Self Injection Device Sales by Type
- 4.2.1 Global Self Injection Device Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Self Injection Device Sales by Type (2021-2032)
- 4.2.3 Global Self Injection Device Sales Market Share by Type (2021-2032)
- 4.3 Global Self Injection Device Revenue by Type
- 4.3.1 Global Self Injection Device Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Self Injection Device Revenue by Type (2021-2032)
- 4.3.3 Global Self Injection Device Revenue Market Share by Type (2021-2032)
5 Self Injection Device Market by Application
- 5.1 Self Injection Device Application Introduction
- 5.1.1 Insulin Injection
- 5.1.2 Epinephrine Injection
- 5.1.3 Others
- 5.2 Global Self Injection Device Sales by Application
- 5.2.1 Global Self Injection Device Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Self Injection Device Sales by Application (2021-2032)
- 5.2.3 Global Self Injection Device Sales Market Share by Application (2021-2032)
- 5.3 Global Self Injection Device Revenue by Application
- 5.3.1 Global Self Injection Device Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Self Injection Device Revenue by Application (2021-2032)
- 5.3.3 Global Self Injection Device Revenue Market Share by Application (2021-2032)
6 Global Self Injection Device Sales by Region
- 6.1 Global Self Injection Device Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Self Injection Device Sales by Region (2021-2032)
- 6.2.1 Global Self Injection Device Sales by Region (2021-2026)
- 6.2.2 Global Self Injection Device Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Self Injection Device Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Self Injection Device Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Self Injection Device Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Self Injection Device Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Self Injection Device Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Self Injection Device Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Self Injection Device Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Self Injection Device Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Self Injection Device Revenue by Region
- 7.1 Global Self Injection Device Revenue by Region
- 7.1.1 Global Self Injection Device Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Self Injection Device Revenue by Region (2021-2026)
- 7.1.3 Global Self Injection Device Revenue by Region (2027-2032)
- 7.1.4 Global Self Injection Device Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Self Injection Device Revenue (2021-2032)
- 7.2.2 North America Self Injection Device Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Self Injection Device Revenue (2021-2032)
- 7.3.2 Europe Self Injection Device Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Self Injection Device Revenue (2021-2032)
- 7.4.2 Asia-Pacific Self Injection Device Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Self Injection Device Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Self Injection Device Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 Novo Nordisk
- 8.1.1 Novo Nordisk Company Information
- 8.1.2 Novo Nordisk Business Overview
- 8.1.3 Novo Nordisk Self Injection Device Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 Novo Nordisk Self Injection Device Product Portfolio
- 8.1.5 Novo Nordisk Recent Developments
- 8.2 Mylan
- 8.2.1 Mylan Company Information
- 8.2.2 Mylan Business Overview
- 8.2.3 Mylan Self Injection Device Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Mylan Self Injection Device Product Portfolio
- 8.2.5 Mylan Recent Developments
- 8.3 Pfizer
- 8.3.1 Pfizer Company Information
- 8.3.2 Pfizer Business Overview
- 8.3.3 Pfizer Self Injection Device Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 Pfizer Self Injection Device Product Portfolio
- 8.3.5 Pfizer Recent Developments
- 8.4 Sanofi
- 8.4.1 Sanofi Company Information
- 8.4.2 Sanofi Business Overview
- 8.4.3 Sanofi Self Injection Device Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 Sanofi Self Injection Device Product Portfolio
- 8.4.5 Sanofi Recent Developments
- 8.5 BD
- 8.5.1 BD Company Information
- 8.5.2 BD Business Overview
- 8.5.3 BD Self Injection Device Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 BD Self Injection Device Product Portfolio
- 8.5.5 BD Recent Developments
- 8.6 Eli Lilly
- 8.6.1 Eli Lilly Company Information
- 8.6.2 Eli Lilly Business Overview
- 8.6.3 Eli Lilly Self Injection Device Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 Eli Lilly Self Injection Device Product Portfolio
- 8.6.5 Eli Lilly Recent Developments
- 8.7 Gerresheimer
- 8.7.1 Gerresheimer Company Information
- 8.7.2 Gerresheimer Business Overview
- 8.7.3 Gerresheimer Self Injection Device Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.7.4 Gerresheimer Self Injection Device Product Portfolio
- 8.7.5 Gerresheimer Recent Developments
- 8.8 Dongbao
- 8.8.1 Dongbao Company Information
- 8.8.2 Dongbao Business Overview
- 8.8.3 Dongbao Self Injection Device Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.8.4 Dongbao Self Injection Device Product Portfolio
- 8.8.5 Dongbao Recent Developments
- 8.9 Ypsomed
- 8.9.1 Ypsomed Company Information
- 8.9.2 Ypsomed Business Overview
- 8.9.3 Ypsomed Self Injection Device Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.9.4 Ypsomed Self Injection Device Product Portfolio
- 8.9.5 Ypsomed Recent Developments
- 8.10 Owen Mumford
- 8.10.1 Owen Mumford Company Information
- 8.10.2 Owen Mumford Business Overview
- 8.10.3 Owen Mumford Self Injection Device Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.10.4 Owen Mumford Self Injection Device Product Portfolio
- 8.10.5 Owen Mumford Recent Developments
- 8.11 Antares Pharma
- 8.11.1 Antares Pharma Company Information
- 8.11.2 Antares Pharma Business Overview
- 8.11.3 Antares Pharma Self Injection Device Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.11.4 Antares Pharma Self Injection Device Product Portfolio
- 8.11.5 Antares Pharma Recent Developments
- 8.12 Haselmeier
- 8.12.1 Haselmeier Company Information
- 8.12.2 Haselmeier Business Overview
- 8.12.3 Haselmeier Self Injection Device Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.12.4 Haselmeier Self Injection Device Product Portfolio
- 8.12.5 Haselmeier Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Self Injection Device Value Chain Analysis
- 9.1.1 Self Injection Device Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Self Injection Device Production Mode & Process
- 9.2 Self Injection Device Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Self Injection Device Distributors
- 9.2.3 Self Injection Device Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst